Percutaneous ablation of malignant thoracic tumors
Lung cancer is the leading cause of death related to cancer. Fifteen to thirty percent of patients with a localized lung cancer are actually inoperable as they present with poor general condition, limited cardiopulmonary function, or a too high surgical risk. Therefore, minimally invasive treatments...
Main Author: | B Ghaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2013-05-01
|
Series: | Journal of the Belgian Society of Radiology |
Subjects: | |
Online Access: | https://www.jbsr.be/articles/235 |
Similar Items
-
Surgically Resected Giant Tumor in the Thoracic Cavity
by: Juan QI, et al.
Published: (2010-08-01) -
Recent Developments and Perspectives of Endobronchial Ultrasound in Thoracic Tumor
by: Shuanying YANG, et al.
Published: (2010-05-01) -
Thoracic paravertebral block for the anesthetic management of percutaneous radiofrequency ablation of liver tumors
by: Mohamed M Abu Elyazed, et al.
Published: (2018-01-01) -
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
by: A. Scherpereel, et al.
Published: (2010-10-01) -
Surgical Treatment of Thoracic Giant Tumor: A Report of 32 Cases
by: Guanghong XIE, et al.
Published: (2008-04-01)